Detection of Human Circulating and Extracellular Vesicle-Derived miRNAs in Serum of Humanized Mice Transplanted with Human Breast Cancer (HER2+ and TNBC) Cells-A Proof of Principle Investigation

Chen, I-Peng and Henning, Stefan and Bender, Marc and Degenhardt, Sarah and Ghodbani, Mouna Mhamdi and Bergmann, Ann Kathrin and Volkmer, Beate and Brockhoff, Gero and Wege, Anja Kathrin and Greinert, Ruediger (2025) Detection of Human Circulating and Extracellular Vesicle-Derived miRNAs in Serum of Humanized Mice Transplanted with Human Breast Cancer (HER2+ and TNBC) Cells-A Proof of Principle Investigation. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 26 (8): 3629. ISSN 1661-6596, 1422-0067

Full text not available from this repository. (Request a copy)

Abstract

Humanized tumor mice (HTM) allow for preclinical cancer treatment studies of breast cancer (BC) under human-like conditions. This study utilized HTM for the first time to investigate potential miRNA biomarker candidates for treatment response in sera and extracellular vesicles (EVs), following X-irradiation and atezolizumab (anti-PD-L1) treatment. We identified the changes of human-specific miRNAs (miR-23b-3p and miR-155-5p) after irradiation and anti-PD-L1 treatment in HTMs with human epidermal growth factor receptor 2 positive (HER2+ BC) and triple-negative breast cancer (TNBC). The high degree of conserved, circulating free miRNA in mice and men represents a challenge of our assay; however, miRNAs with >= 2 nucleotide mismatches can be employed for human-specific analysis, and even conserved miRNAs may be utilized under clearly defined conditions of human tumor growth in HTM. A comparative analysis of extracellular vesicle miRNA cargo and free-circulating serum miRNAs revealed several exosome-specific miRNAs (miR-29b-3p, miR-34c-5p, miR-203a-3p, miR-378g, and miR-382-5p) in HTMs, which are known to play roles in BC. Our findings demonstrate that HTMs are a suitable model to identify treatment-induced changes in free-circulating and exosomal miRNAs that influence tumor progression and immunological tumor defense, both locally and at distant sites. This study presents a proof-of-principle approach to analyzing cell-free nucleotides and exosomes in a human-like, preclinical in vivo setting. Further refinements are necessary to enhance the sensitivity and the specificity of the HTM-based approach.

Item Type: Article
Uncontrolled Keywords: LIQUID BIOPSY; DOUBLE-BLIND; EXPRESSION; PROGRESSION; MARKER; CHEMOTHERAPY; CARCINOMA; PLUS; humanized tumor mouse; liquid biopsy; miRNA; extracellular vesicles; breast cancer
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Frauenheilkunde und Geburtshilfe (Schwerpunkt Frauenheilkunde)
Depositing User: Dr. Gernot Deinzer
Date Deposited: 17 Nov 2026 06:22
Last Modified: 17 Nov 2026 06:22
URI: https://pred.uni-regensburg.de/id/eprint/66886

Actions (login required)

View Item View Item